2024 Conference

10:30am – 10:50am – Break

10:50am – Discussion – Pros and Cons – Centralized vs PCP referred vs hybrid models
Peter Mazzone, Cleveland Clinic
Andrea McKee, Radiation Oncology Associates, PA / Rescue Lung Society

11:20am – Session II – CT Lung Screening Quality Indicators – Moderator: – Carey Thomson

• Review and Recommendation – IASLC Perspective

Martin Tammemagi, Brock University 

• Rescue Lung Society program quality metrics

Shawn Regis, Rescue Lung Society

• CT Lung Screening proposed HEIDIS measures

Ella Kazerooni, University of Michigan

• Is there an acceptable benign resection rate?  Pro and Con

Dan Raz, City of Hope

Mara Antonoff, MD Anderson  

• Q&A

12:50pm – 2:00pm – Lunch and Visit Exhibitors

2:00pm – Session III – Stigma – Moderator: Jamie Ostroff

• What is the impact of stigma on patients? 

Jill Feldman, EGFR Resistors 

• Reframing Lung Cancer in Public Discourse: The Role of the Lung Cancer Stigma Communications Assessment Tool (LCS-CAT)

Lisa Carter-Bawa, Hackensack Meridian Health

• Lung Cancer Stigma in Europe 

Anne-Marie Baird, Lung Cancer Europe 

• Impact of Tobacco Control Policy on lung cancer stigma – pro-con discussion  

Matthew Steliga, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences

Andrea Borondy Kitts, Rescue Lung Society

• Q&A

3:30pm – 3:50pm – Break

3:50pm – Session IV – Screening Criteria and Addressing Disparities – Moderator: Matt Smeltzer

• Lung Cancer Risk Prediction – Indigenous Models for Heterogenous Populations

Martin Tammemagi, Brock University

• CTLS in New Zealand Focusing on Screening Indigenous Population

Sue Crengle, University of Otago

• Disparities in eligibility using pack years criteria

Alexandra Potter, American Lung Cancer Screening Initiative

• Simplify eligibility criteria to “if ever smoked” vs age/smoking history vs individual risk prediction models -pro/con

Doug Wood, University of Washington

Kevin ten Haaf, Erasmus

5:30pm – 6:30pm – Reception and Visit Exhibitors

6:30pm – 8:30pm – Dinner

7:00am – Breakfast and Registration

8:00am – Brady McKee Excellence in Lung Cancer Screening Award – Andrea McKee

8:30am – Session V- Research, Clinical Trials, and Studies – Moderator: Harry de Koning

• • Notification of Coronary Artery Calcium on Lung Screening CT: a New Way to Reduce Risk of Cardiac Events

  David Maron, Stanford 

  • Impact of a community support program on adherence to LCS follow-up in an urban environment

  Farouk Dako, University of Pennsylvania

  • HIV and risk of lung cancer

  Randi Williams, Georgetown University Medical Center

  • INSPIRE Lung Cancer Screening Study for High-risk Black Women Who May Not Meet the 2021 USPSTF Lung Cancer Screening Eligibility Criteria in Boston and Chicago

  Jeff Yang – Massachusetts General Hospital

  • Lung Cancer Screening in Asians that never smoked

  Elaine Shum, NYU Langone Health

  • LuCNeSS Study – lung cancer in those who never smoked

  AJ Piper, Lahey Hospital & Medical Center

10:30am – 11:00am – Break

11:00am – Session V- Research, Clinical Trials, and Studies – Continued

• Boston Firefighters CT Lung Screening program

Erica Warner, Massachusetts General Hospital

• Expanding LCS criteria in the VA population

Lucy Spalluto, Vanderbilt University Medical Center

11:50am – 1:00pm – Lunch and Visit Exhibitors

1:00pm – Session VI -Lung Cancer Screening, Biomarkers and AI – Moderator: Luis Montuenga

• Risk Prediction with Biomarkers

Hana Zahed, IARC 

• The SUMMIT Study

Monica Mullin, University College London and University of British Columbia

• Sybil

Allison Chang, Massachusetts General Hospital and Dana-Farber Cancer Institute

• Breathomics

Renelle Myers, University of British Columbia

• Imaging and clinical data

Joey Bargo, Baptist Health and Thynk Health

2:40pm – 3:00pm – Break

3:00pm – Session VII — Advocacy and Legislative Initiatives – Moderator: Andrea Ferris